Product Specifications: Lyophilized Powder (>99% purity) in 3ml vial. *Requires Reconstitution ** Available for bulk custom order with 57 Cap/Crimp colors to choose from.
Application: Research bioregulator studied for respiratory function improvement and repair, immunology, cellular repair, anti-inflamation
Chemical Formula: C18H30N4O9
Molecular Weight: ~446.45 g/mol
Concentration: ≥99%
Bronchogen, also known as AEDL, is a synthetic tetrapeptide bioregulator composed of the amino acid sequence Ala-Glu-Asp-Leu.
Respiratory Health Applications
Bronchogen is extensively studied for its respiratory health benefits, with research focusing on:
- Treatment of chronic obstructive pulmonary disease (COPD)
- Bronchodilation effects in respiratory conditions
- Structural and functional remodeling of the bronchial epithelium
- Supporting respiratory health and facilitating lung tissue repair
- Potential therapeutic applications in asthma
- Cellular repair processes within lung tissue
Anti-Inflammatory Properties
Research has demonstrated Bronchogen's significant anti-inflammatory capabilities:
- Reduction of inflammation in respiratory conditions
- Treatment of inflammatory diseases beyond the respiratory system
- Decreasing inflammation and promoting healthy lung tissue regeneration in rat models
Gene Expression and Regulation
Bronchogen shows promising effects on genetic regulation:
- Regulation of gene expression and protein synthesis related to lung cell function
- Involvement in regulation of bronchial epithelium functional activity
- Influence on DNA transcription pathways
Immune System Modulation
Studies are examining Bronchogen's immunomodulatory properties:
- Effects on immune cell function
- Cytokine production regulation
- Potential applications in immunotherapy
Emerging Research Areas
Recent studies have expanded into new applications:
- Potential therapeutic use in COVID-19 treatment
- Investigation of bronchoprotective properties
References:
Anisimov, V. N., & Khavinson, V. K. (2010). Peptide bioregulation of aging: Results and prospects. Biogerontology, 11(2), 139-149. https://doi.org/10.1007/s10522-009-9249-8
Khavinson, V. K., Kuznik, B. I., & Ryzhak, G. A. (2014). Peptide bioregulators: A new class of geroprotectors. Message 1: Results of experimental studies. Advances in Gerontology, 4(4), 298-301. https://doi.org/10.1134/S2079057014040080
Korkushko, O. V., Khavinson, V. K., Shatilo, V. B., & Antonyuk-Shcheglova, I. A. (2011). Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: Results of 15-year follow-up. Bulletin of Experimental Biology and Medicine, 151(3), 366-369. https://doi.org/10.1007/s10517-011-1332-x
Disclaimer: This product is intended solely for laboratory research purposes. It is not suitable for consumption by humans, nor for medical, veterinary, or household purposes. Researchers should handle all peptides with care and adhere to strict safety guidelines during experiments. Only qualified professionals with appropriate expertise should manage and handle this product. The distributor, manufacturer, and seller of this product are not responsible for misuse or any resulting consequences. By accessing this product, you consent to comply with these terms and conditions.
